The Importance of the Scaffold for de Novo Enzymes: A Case Study with Kemp Eliminase. by Bhowmick, Asmit et al.
UC Berkeley
UC Berkeley Previously Published Works
Title
The Importance of the Scaffold for de Novo Enzymes: A Case Study with Kemp Eliminase
Permalink
https://escholarship.org/uc/item/6k77v6j1
Journal
Journal of the American Chemical Society, 139(16)
ISSN
0002-7863
Authors
Bhowmick, A
Sharma, SC
Head-Gordon, T
Publication Date
2017-04-26
DOI
10.1021/jacs.6b12265
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
The Importance of the Scaffold for de Novo Enzymes: a case study
with Kemp Eliminase
Asmit Bhowmick1, Sudhir C. Sharma2, and Teresa Head-Gordon1,2,3,4*
1Department of Chemical and Biomolecular Engineering, 2Department of Chemistry, and
3Department of Bioengineering, University of California Berkeley
4Chemical Sciences Division, Lawrence Berkeley National Labs
Berkeley, California 94720, USA
Abstract
We report electric field values relevant to the reactant and transition states of designed Kemp
eliminases  KE07 and KE70,  and their  improved variants  from laboratory directed evolution
(LDE), using atomistic simulations with the AMOEBA polarizable force field. We find that the
catalytic base residue contributes the most to the electric field stabilization of the transition state
of the LDE variants of the KE07 and KE70 enzymes, whereas the electric fields of the remainder
of the enzyme and solvent disfavor the catalytic reaction in both cases. By contrast, we show that
the electrostatic environment plays a large and stabilizing role for the naturally occurring enzyme
ketosteroid isomerase (KSI). These results suggest that LDE is ultimately a limited strategy for
improving de novo enzymes since it is largely restricted to optimization of chemical positioning
in the active site, thus yielding a ~3 order magnitude improvement over the uncatalyzed reaction,
which  we  suggest  may  be  an  absolute  upper  bound  estimate  based  on  LDE  applied  to
comparable de novo Kemp Eliminases and other enzymes like KSI. Instead de novo enzymatic
reactions could more productively benefit from optimization of the electrostatics of the protein
scaffold  in  early  stages  of  the  computational  design,  utilizing  electric  field  optimization  as
guidance.
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INTRODUCTION
Although the design of new biocatalysts has not yet reached the level of proficiency of naturally
occurring enzymes, there is optimism that further progress toward that goal is realistic and within
reach as our understanding deepens on why current efforts have fallen short1 and what makes
natural enzymes so exceptional2-3. In this work we consider de novo enzyme design whereby a
small catalytic “theozyme” is placed into an accommodating native protein scaffold, i.e. one that
remains stable4-5.  While minimal activity is observed for these de novo designed enzymes, it is
still orders of magnitude below the activity typically seen in natural enzymes. While computation
has provided insight6-9 and useful  improvements10-12,  the  majority  of  the improvement  comes
from laboratory directed evolution (LDE)13, which alters the protein sequence through multiple
rounds of mutagenesis  and selection to  isolate  the few new sequences that  exhibit  enhanced
catalytic performance.14-18 
This process is  well-illustrated by the  de novo design of the  Kemp elimination (KE)
reaction5, involving the deprotonation of the ligand substrate 5-nitrobenzisoxazole by a catalytic
base  (Figure  1)5,  with corresponding electronic rearrangements that  break the  C-H and N-O
bonds while forming a C≡N triple bond. Most designs have been engineered into related TIM
barrel scaffolds, although sequence identity among them is low, and then are optimized with
LDE to create  different catalytic motifs such as KE0714,  KE7015,  KE5918,  and HG3.1717.  For
KE07 and KE70, the focus of our study here, the majority of catalytic performance was obtained
after 6-7 rounds of LDE, which improved the kcat/KM by a factor of ~200 (KE07.R7) and ~400
(KE70.R6),  respectively,  in the best evolved enzymes (see Table S1 and Figure S1).14-15 It  is
noteworthy that while most of the catalytic improvement for KE07 resulted from increases in kcat,
the improvements in KE70 were derived equally from kcat and KM, and would suggest that LDE
took very different strategies in the optimization of the two enzymes.14-15
Figure  1: The  Kemp  elimination  reaction.  The  one-step  reaction  scheme  involving  the
abstraction of hydrogen from the carbon of 5-nitrobenzisoxazole by a catalytic base. Shown is
the transition state that has a partial negative charge on the substrate oxygen with cleavage of the
O-N bond and nascent formation of a C≡N triple bond.
Almost all design protocols for Kemp Eliminases19-22 have taken a minimalist strategy of placing
a base in a hydrophobic pocket, thus increasing the pKa. For example, catalytic antibody 34E4
can catalyze the Kemp elimination reaction with efficiencies comparable to the KE07.R7 variant
using a simplified active site motif of a functional base surrounded by hydrophobic residues23.
Similar rudimentary Kemp eliminases have also been designed not only into TIM barrels5, 10, 14-15,
17-18, but into scaffolds of calmodulin24 and T4-lysozyme25. Thus, regardless of the fold involved,
a basic level of activity can be obtained for this reaction.1 However, to reach the level of natural
enzymes, there needs to be synergism between multiple functional groups23 that includes not only
hydrophobicity  but  beneficial  electrostatic  contributions2-3.  Furthermore,  electrostatic
stabilization comes not only from the proximity of a few residues in the active site26-27, but also
the rest of the protein scaffold28-30 as well as the surrounding solvent31-32.
Advances in vibrational Stark effect (VSE) spectroscopy30 have enabled researchers to
probe the electric field in the active site of enzymes in order to quantify their contribution to the
observed acceleration of reaction rates over the uncatalyzed reaction in aqueous solvent.  An
electric  field  can  have  a  catalytic  effect  if  it  adopts  a  sustained  direction  that  specifically
stabilizes the transition state in preference to the reactant state—an effect that in principle is
better optimized in the pre-organized state of an enzyme relative to bulk aqueous environment2-3,
29, 33. Using VSE for the ketosteroid isomerase (KSI) enzyme and its inhibitor 19-nortestosterone
(19NT), which has a C=O group located in the same position as the carbonyl group of it’s natural
substrate in the active site, Fried and co-workers have shown that the large electric fields exerted
on this  bond were  linearly correlated with the  activation  free energies  of  the  wild type  and
mutated variants.29, 34 Although precise chemical positioning of the Asp40 base in the active site
for  proton  abstraction  from  the  substrate  is  important  for  KSI27,  leading  to  transition  state
stabilization  that  contributes  2-3  orders  of  magnitude  to  the  observed  accelerated  rate,  the
analysis of the VSE data suggests that ~5 orders of magnitude improvement in kcat comes about
due to the reduction in the catalytic barrier that arises from the electrostatic environment of the
KSI  protein29,  35.  Although  there  is  disagreement  on  the  relative  orders  of  magnitude  that
electrostatics  contributes  to  the  chemical  base  positioning  vs.  the  scaffold  and  solvent
contributions27,  36,  there  is  no  question  that  each  are  highly  important  for  the  catalytic
performance of naturally occurring enzymes.
Presumably natural enzymes like KSI have developed highly optimized structural folds,
including  surfaces  that  invoke  additional  favorable  orientations  of  solvent  dipoles,  which
together contribute to a long-ranged and organized electrostatic environment for biocatalysis.2-3
However, for  de novo designed enzymes it is reasonable to assume that they suffer from both
non-optimal chemical positioning as well as a poorly concocted electrostatic environment, since
the scaffold merely serves as a “backdrop” for containing the designed active site. In this work,
we decipher the contribution of electrostatic pre-organization to transition state stabilization in
the designed Kemp enzymes KE07 and KE70, and to demonstrate how the electrostatics are
further tuned by LDE to improve the catalytic activity for both. 
Using  atomistic  computer  simulations  with  an  advanced  polarizable  force  field,  we
measure the electric field at the 3 bonds that are made or broken in the ligand bound enzyme
(EL) and transition state (EL†) as shown in Figure 2. While Labas et al. considered all bonds of
the substrate37, we focus on only these 3 bonds since their electronic bonding changes result in
bond dipoles that show the greatest difference between the EL and EL† states (Table S2). While
the 5-nitro group (Figure 1) might also play a role, under the AMOEBA electrostatic model we
have found that the bond dipole difference between the EL and EL†  states for the N-O bond of
this group are negligible compared to the reactive bonds (Table S2), so that a sizeable effect from
this group can be ruled out.  
Figure  2: Electric  field  projection  onto  the  C-H,  C-N,  and  O-N  bond  dipoles  of  5-
nitrobenzisoxazole and sign convention used. Electric fields are calculated at the C, H, N and O
of the ligand, in which the critical chemical step of the reaction is the breaking of the C-H and O-
N bonds and the making of the C-N triple bond. The positive field direction shown by arrows is
chosen to conform to the opposite direction of movement of electrons in the Kemp elimination
reaction, a favorable field direction that supports the transition state.
Furthermore,  transition  state  free  energy  stabilization  from bond dipoles  and electric
fields can be evaluated as 
μ´
¿
−¿
ΔGelec
‡ =¿
) (1)
where ❑´  is the bond dipole and E´  is the electric field evaluated in the EL and EL† states.
Finally,  we have  decomposed the  electric  fields  into  contributions  from each residue  of  the
enzyme33 as well as solvent to better distinguish between “chemical positioning” of the catalytic
base  in  the  active  site,  and  the  contributions  that  arise  from the  longer-ranged electrostatic
environment from the protein and solvent. 
We find that electrostatic fields are far greater in the active site of the enzymes relative to
bulk solution when projected onto the relevant bonds, and a significant change in electrostatic
pre-organization was found when going from the designed enzyme to the most improved variant
for KE07 but not KE70. We find that chemical positioning, i.e. the optimization of the active site
base  that  interacts  directly  with  the  substrate,  contributes  the  most  to  the  electric  field
environments for KE07 and KE07.R7, whereas the stabilization effect of the electrostatic field is
still present but smaller in the designed KE70 enzyme, and does not improve in the LDE variant
due to many mutations to hydrophobic amino acids that promote substrate affinity for the active
site instead. 
But  in  all  cases,  whether  designed  or  LDE optimized,  the  electrostatic  fields  of  the
remainder of the enzyme and solvent disfavor the catalytic reaction.  By contrast, we show that
the  electrostatic  environment  contributes  a  large  stabilizing  role  for  the  naturally  occurring
enzyme  ketosteroid  isomerase  bound to  the  19NT inhibitor.  The  underlying  premise  of  the
design approach – construction of a new catalytic “theozyme” that is placed into an  arbitrary
protein  fold  –  suggests  that  one  of  the  primary  limitations  of  the  de  novo strategy  is  the
restriction of the LDE search to optimization of chemical positioning in the active site, with an
upper bound of ~3 orders of magnitude estimated from LDE applied to comparable  de novo
Kemp Eliminases17 and estimates made for natural enzymes like KSI26-27, 29, 34-36. Instead de novo
enzymatic reactions would most productively benefit from optimization of the protein scaffold38
in earlier stages of the computational design, utilizing electric field optimization as guidance, to
recover the many missing orders magnitude improvements from electric field environments.
METHODS
Generating backbone and side chain ensembles for EL and EL† states of KE07 and KE70.  For
both enzymes, the initial design was modeled using the structures reported in reference [ 14-15]
with the ligand docked in the appropriate position. Starting structures for improved variants for
both cases (R7 for KE07 and R6 for KE70) were generated using Modeller.  Using each of these
PDB/modeled structures for the backbone in the ligand bound state, we then used the backrub
algorithm implemented in Rosetta to run 25 independent simulations, each generating 10,000
trial moves using the Cα atoms as pivot residues, to generate uncorrelated backbone ensembles.
From each simulation the lowest energy structure was saved. Since the backbone scaffolds for
KE07 and KE70 are  quite  rigid,  we believe the  backbone variations we have  generated are
adequate. 
With these 25 backrub structures, we then used a recently developed Monte Carlo Side
Chain Ensemble (MC-SCE) method39 to create large side chain ensembles for each structure.
MC-SCE has been validated across a large number of proteins and protein complexes in which it
performed  extremely  well  in  predicting  observables  reported  in  high  quality  X-ray
crystallography and NMR J-coupling experiments.39 We note that for the MC-SCE calculation,
the substrate was kept fixed in the docked position in both the EL and EL †  state. The substrate
geometry for the EL† state was the same as in the EL state with only the charges changed to
reflect  the  transition  state  nature.  The  resulting  structural  ensembles  for  KE07  and  KE70
represent sampling on the microsecond to millisecond timescale as estimated from repacking of
the amino acid sidechains on different backbones. 
Molecular dynamics simulations with AMOEBA. From the MC-SCE simulations on each
backbone for the EL and EL† states of KE07 and KE70, we save the lowest energy structure
which is then used as the starting point for molecular dynamics simulations with the AMOEBA
polarizable  force  field40-42.  The  AMOEBA model  is  described  using  a  permanent  multipole
expansion up to quadrupoles, and polarization effects are explicitly accounted for by calculating
induced dipoles in a self-consistent manner. Due to the sophistication of electrostatics and short-
ranged anisotropic interactions,  AMOEBA should provide an excellent model for the electric
fields in enzymes.
All the MD simulations in this study were performed using TINKER software. The tleap
module in AMBER was used to solvate the system with a 10 Å spacing between the solute and
the nearest box edge. Minimization was then performed using an LBFGS scheme with gradient
RMS cutoff of 0.01. After minimization, an NPT simulation was performed with a timestep of
1fs integrated by the Beeman scheme. The temperature was maintained at 298 K with a Nose-
Hoover thermostat. The PME real space cutoff and Van der Waals cutoff was set to 8 Å. Induced
dipoles were iterated until the root-mean-square change was less than 10 -5 Debye/atom. Given
the ensemble of structures from the molecular dynamics and MC-SCE calculations described
above, which provides effective sampling over much longer timescales than an individual and
standard tens of nanosecond trajectory, we run 25 independent 100 ps trajectories of which we
discard the first 50 ps and then collect statistics for the remaining 50 ps at intervals of 1 ps.
Electric field values were calculated at the 4 atoms in the ligand involved in the breaking and
making of chemical bonds in the substrate, namely C, H, N and O as shown in Figure 2. This was
done for EL and EL† states in both designed enzymes and best LDE variants.
Electric  field  calculations.  In  the  AMOEBA framework,  the  permanent  and  induced
electric fields at atom i due to another atom j can be written as follows
Eperm ,α
(i , j) =−T α q
( j)+T αβ μ❑
( j ,β )−1
3
T αβγ Θ
( j , β , γ ) (2a)
Eind ,α
(i , j) =T αβ μind
( j , β ) (2b)
where  α , β , γ=x , y , z  and  q,  ,   correspond  to  point  charge,  point  dipole,  and  point
quadrupole permanent electrostatics, ind is the polarizable dipole, and the tensor T is expressed
in a compact format as 
T αβ … ν=
1
4 π ϵ 0
∇α∇β …∇ν ( 1R ) (2c)
Although  during  the  dynamical  simulation  the  long-ranged  electrostatics  of  the  many-body
polarization are evaluated under Ewald, in order to break down the electric field contributions
from specific residues, we do an extra calculation where the induced dipoles are again calculated
to convergence but using the real-space interactions only, with no cutoff’s, and then Eq. (2a-2c)
is calculated. When we add up all real-space contributions from all residues j to define the total
electric field at the i=C, N, O, and H atoms of the substrate,
Eα
(i )=∑
[ j ]
Eα
(i , j )
(3)
we determine errors of ~1.0% when we compare to the full Ewald calculation. 
Once we know the electric field values at atomic site i due to site j, the electric field
values at a bond are then evaluated as the arithmetic mean of the field values at the 2 atoms
forming  the  bond.  For  example,  along  coordinate  axis  α,  the  average  field  at  the  bond  b ik
comprised of atoms i and k due to residue j is 
Eα
(bik , j)=( Eα(i , j)+Eα(k , j)) /2α=x , y , z (4)
Field values along a bond are then calculated by taking the dot product between the electric field
vector at the bond (Eq. 4) and the unit vector of the bond with positive direction illustrated in Fig
2. These values have been reported in all Tables and Figures. In all the 3 bonds studied here, we
chose the positive direction of the field to be opposite to the direction of movement of electron in
the bond breaking or bond making process. This is shown in Figure 2 with the arrows illustrating
the positive field direction for each bond.
KSI Simulations. In addition to simulations of designed enzymes KE07 and KE70, we
also  carried  out  electric  field  calculations  for  the  natural  enzyme KSI  in  complex with  the
inhibitor 19-nortestosterone (19NT), the structure of which was recently published  (PDB ID:
5KP4). The same protocol as used for KE07/KE70 was followed to calculate the fields. First
backrub calculations  were  done with the  inhibitor  in  the  bound state  to  introduce  backbone
variability. Next, MC-SCE calculations were done on 25 of these backrub structures to model
side  chain  variability.  The  parameters  for  19NT  inhibitor  for  MC-SCE  calculations  were
generated using Antechamber. The lowest energy structure from each of the MC-SCE ensembles
were used as input for electrostatics calculations with AMOEBA. The same protocol as described
above was followed for the field calculation,  but now evaluated for the C=O bond of 19NT
inhibitor.  Parameters  for  19NT  for  AMOEBA simulations  were  generated  using  the  same
protocol described in SI material for the 5-nitrobenzisoxazole substrate in reactant state.
RESULTS
We first calculate the activation free energy stabilization of the transition state EL † relative to the
reactant  state  EL due  to  electrostatics,  ΔGelec
‡  using  Eq.  (1)  in  order  to  determine  its
contribution to the observed rate enhancements, i.e. on kcat 
kcat=
kT
h
e−β Δ Gelec
‡
e−β ΔG other
‡
(5)
By convention, field directions that are aligned with the breakage of the C-H and N-O single
bonds, and fields aligned in the opposite direction for the formation of a C≡N triple bond, would
contribute  to  free  energy stabilization  of  the  transition  state  through electrostatics  (Eq.  (5)).
Using the transition state structure reported in [43] for an acetate base for the same ligand, and
using the  AMOEBA electrostatic  parameters for charges and fixed dipoles,  we can assign  a
Gelec
≠  contribution to the C-H, N-O, and C≡N bond dipoles in the EL and EL† states (see the SI
material and Table S2 for details). The incipient bond in the transition state between the base
oxygen/nitrogen and the abstracted hydrogen was not considered for this study. 
It is important to note that we are missing other contributions to the total free energy
barrier, ΔGother
‡ , such as the entropic effects arising from desolvation (although the enthalpic
interactions are likely accounted for in part by the solvent electrostatic field contributions in
Gelec
‡ ).  In addition, we have shown that side chain entropy played a significant role in the
observed kcat trends for which the active site of the original KE07 and KE70 enzymes were over-
designed for the binding affinity of the EL state, whereas the LDE optimized enzymes stabilized
the  EL† complex instead.9 Therefore,  while  experimentally  the  ∆ ΔGtotal
‡ = –2.6  kcal/mole
accounts for the ~70X improvement in kcat for the best KE07 variant compared to the design, and
the corresponding free energy barrier reduction  ∆ ΔGtotal
‡ = –2.1 kcal/mole accounts for the
~35X  improvement  in  kcat for  the  best  KE70  variant,  we  are  only  analyzing  electric  field
contributions  ΔGelec
‡  and thus do not expect to reproduce these total activation free energy
values.
Table 1: Free energy stabilization of the transition state. Reduction in activated free energies are
calculated using ΔGelec
‡   = –0.048(FTS•μTS – FS•μS). Electric field values along the 3 bonds of
the substrate 5-nitrobenzisoxazole in the EL and EL† states of KE07 and KE70 designed enzymes
and  best  LDE  variants,  as  well  as  in  aqueous  solvent.  Positive  field  indicates  favorable
contribution  and fields  are  reported in  units  of  MV/cm. Standard  error  of  the  means are  in
parentheses. Bond dipole moments are estimated from AMOEBA charges and fixed dipoles (see
SI material) in the EL and EL† complexes; for C-H μTS = 1.0D, μS = –1.0D; for C≡N μTS = 0.4D,
μS =2.0D; for O-N μTS = 2.3D, μS =–1.7D.
Enzyme Construct and ΔGelec
‡
(kcal/mole)
Fields and ΔGelec
‡  (kcal/mole) generated for
each bond
C-H C≡N O-N
Designed KE07 EL 47.6 (3.9) 43.9 (2.0) 3.7 (2.7)EL† 68.7  (7.3) 58.8 (4.1) 22.7 (2.2)
∑
bonds
Δ Gelec
‡
= –5.3 –5.6 3.1 –2.8 
LDE R7 Variant KE07
EL 81.5 (11.0) 49.1 (4.3) 7.2 (3.7)
EL† 108.2 (12.9) 77.8 (9.6) 30.3 (3.7)
∑
bonds
Δ Gelec
‡
= –9.9 –9.1 3.2 –4.0 
Designed KE70 EL 53.3 (3.6) 48.7 (2.4) 8.8 (1.7)EL† 77.6 (3.7) 62.2 (1.8) 28.1 (1.2)
∑
bonds
Δ Gelec
‡
= –6.6 –6.3 3.5 –3.8 
LDE R6 Variant KE70 EL 54.0 (3.8) 29.7 (1.7) 6.9 (1.1)EL† 76.7 (2.6) 37.0 (1.6) 16.8 (0.9)
∑
bonds
Δ Gelec
‡
= –6.6 -6.3 2.1 –2.4 
Substrate in water
EL 27.3 36.8 –10.5
EL† 48.8 66.7 15.8
∑
bonds
Δ Gelec
‡
= –2.2   –3.6 2.3 –0.9 
Table  1  reports  the  total  electrostatic  field  values  along the  3  relevant  bonds  of  the
substrate  5-nitrobenzisoxazole  in  the  EL and  EL†  states  of  the  KE07  and  KE70  designed
enzymes, and their corresponding best LDE variants, as well as the fields acting on the reactant
and  transition  state  in  aqueous  solvent.  If  we  assume  that  the  electrostatic  contribution  to
ΔGelec
≠  arises from the additive contributions from the 3 bonds, then we can draw several
immediate conclusions. The first is that the designed enzymes and their LDE variants help focus
and enhance the electric fields along these bonds relative to the electric fields in bulk solvent,
and overall  the  transition  state  is  stabilized in  preference  to  the  reactant  state  regardless  of
enzyme  variants  (and  which  is  true  even  in  bulk  solvent).  In  addition,  the  electric  field
stabilization is better for the designed KE70 relative to the designed KE07 enzyme, consistent
with the fact that the  kcat of the former is an order of magnitude better than the latter. Finally,
while for KE07 there is a very clear trend of increasing electric field strength going from the
designed enzyme to the best R7 variant in both EL and EL† states for all  relevant substrate
chemical bonds, the KE70 enzyme exhibits no net activated free energy decrease in going from
the designed to the best R6 LDE variant. 
While it is apparent that there is transition state stabilization, we further consider whether
the activation free energy is attributable to pre-organization, i.e. changes in the bond dipoles29-30
without  any  corresponding  relaxation  of  the  structural  ensemble  in  response,  relative  to
reorganization  that  accounts  for  that  relaxation  cost.  Table  S3  shows  that  the  adiabatic
contribution, i.e. changes in the transition state stabilization due to bond dipoles by averaging
over the reactant ensemble only, is the dominant contribution to the free energy, with negligible
contributions due to reorganization when averaging over the relaxed transition state ensemble. 
In the case of KE07, when we break down the contributions to the total electric field for
the  C-H,  C≡N, and  N-O  bonds  from  individual  residues  (Table  S4),  we  see  that  the
overwhelming contribution comes from the catalytic  base Glu-101 (Figure 3a),  and the field
strength contributed by the Glu-101 in the R7 variant increases by an additional ~25-40 MV/cm
over the designed KE07 enzyme, a huge improvement for transition state stabilization. There are
also significant stabilizing electric field contributions (> kbT ~10 MV/cm) arising from His201,
and in the best LDE R7 variant from the Gly202Arg substitution,  which we have shown in
previous work interacts directly with the substrate to aid in chemical positioning of the base9.
However in both the KE07 design and R7 variant, the designed residues Lys-222 and Ser-
48,  originally  intended  to  stabilize  the  charge  of  the  substrate  in  the  transition  state,  have
electrostatic fields that negatively impact the activation free energy. We and others have shown
that Lys222 often forms a hydrogen bond with Ser48, as well as with residues Glu46 and Ile7 or
its  replacement  in  LDE R4 with  Asp7,  that  help  support  the  catalytic  purpose  of  KE07 by
removing unproductive interference with the base positioning7, 9. While the Asn224Asp mutation
is  beneficial  for  the  C≡N bond of  the  substrate,  it  is  unproductive  in  regards  electric  field
stabilization44 for the C-H and N-O bonds, such that the net free energy is found to be detrimental
to the catalytic step. Labas et. al also found that the Asn224Asp mutation yielded poor electric
fields when they considered the ligand as a whole37, however our approach of analyzing the 3
main bonds of interest separately provides a potential rationale why the mutation might have
been  introduced  in  the  first  place  since  one  important  transition  state  bond  was  stabilized.
However, a possible alternate purpose for the Asn224Asp mutation is to better complex with
water, as seen in the crystal structure of the R7 variant. Even so, these alternate roles for Lys222,
Ser48,  and  Asp224  come  with  sacrifices  to  activation  free  energy  stabilization  afforded  by
constructive electric field effects on the substrate. 
(a) (b)
Figure 3: The electric field projection onto the C-H bond dipole of 5-nitrobenzisoxazole from
key residues  in  the  active  of  (a)  KE07 and (b)  KE70.  The yellow arrows indicate  the  field
direction/magnitude and the ones in magenta indicate dipole directions for each bond studied. All
residues shown have a field > 10MV/cm (~ kbT) in the transition state of the best variant.
For KE70, there is virtually no overall optimization of the electrostatic fields going from
the designed enzyme to the best R6 variant in both EL and EL† states (Table 1), a result that is
largely orthogonal to  the LDE optimization path taken for KE07. When we break down the
largest contribution to the activation free energy by residue, there is ~25 MV/cm enhancement
from the His-Asp dyad for proton abstraction from carbon in the best R6 enzyme (Figure 3b),
although the majority of the net ~80 MV/cm field strength for the EL† state primarily comes
from  histidine  (Table  S5).  This  is  not  surprising  since  the  main  negative  electric  field
contribution at this bond comes from Arg70 that is known to form unfavorable interactions with
Asp45, thus reducing the pKa of the His-Asp dyad. Otherwise, the electrostatic field due to the
His-Asp  catalytic  base  contributes  negligibly  to  the  stabilization  of  the  other  bonds  of  the
substrate, suggesting that the electric field in KE70 is not as highly optimized as it is in KE07.
What modest gains are made in electric field stabilization of the EL† state for the primary
reactive step of C-H bond breaking in the designed KE70 enzyme are diminished by active site
mutations to more hydrophobic groups (Trp72Cys and Ser138Ala) in the best LDE R6 variant.
For KE70, it appears that other factors like productive binding of the substrate played a more
significant role than electrostatics in the LDE improvement, captured experimentally through an
order of magnitude reduction in KM. In fact the pKa(kcat) ~ 6.2 in both the designed KE70 and R6
LDE  variant,  whereas  for  KE07,  where  the  majority  of  the  improvement  came  through
electrostatic stabilization, the pKa(kcat) changed from < 4.5 in the design to 5.9 in the best R7
LDE variant. 
A lack of stabilization of the oxy-anion is thought to be a bottleneck for the catalytic
reaction  executed  in  catalytic  antibody  34E4,  and  appears  to  be  a  problem for  both  Kemp
Eliminases studied here as can be seen from the electric fields projected onto the N-O bond
dipole  (Tables  S4  and  S5).  Although  LDE  improved  the  electric  fields  for  the  C-H  bond
considerably in KE07, the improvements in the field for the N-O bond were considerably less,
~1.2 kcal/mole of additional stabilization for the KE07.R7 variant. For KE70, this bond breaking
was destabilized by LDE, quite possibly due to the complete removal of Ser-138 whose primary
intent was stabilizing the oxy-anion. As already stated elsewhere23, oxy-anion stabilization may
be  as  critical  as  the  chemical  positioning involving the  proton  abstraction  step.  Taking into
consideration the fact that the O-N bond stabilization energy has the largest sensitivity to electric
field (due to the large change in dipole moments), future efforts will benefit substantially from
designing this  feature  in  earlier  stages,  and is  evidently  a  primary  reason  why the  HG3.17
enzyme improved under LDE17. 
However  the  important  optimization  of  chemical  positioning  and  active  site
improvements may also require further electrostatic stabilization of the transition state by the
scaffold. For natural enzymes such as KSI, Fried et al. have shown that the major contribution to
lowering  the  activation  barrier  comes from the  electrostatic  environment  of  the  enzyme,  as
opposed to the contributions of residues that interact directly with the substrate or residues that
aid in better chemical positioning of the catalytic base. For KSI it was estimated that 102.5 fold
improvement  in  kcat was  due  to  chemical  positioning  whereas  an  additional  ~105 fold
improvement  was  attributable  to  the  electrostatic  “environment”  of  the  protein  scaffold  and
surrounding solvent. While the relative percent contributions due to chemical positioning vs.
electrostatic environment may be questioned27, 36, there is no argument that enzyme folds have
optimized an electrostatic environment that aids the catalytic reaction. 
This is clearly not the case for the designed and LDE optimized KE07 or KE70 enzymes.
Table  2  shows  that  the  electric  fields  from  the  protein  scaffold  and  solvent  are  mostly
counterproductively  aligned  with  the  C-H  bond  for  KE07  and  KE70.  To  validate  this
observation, we performed the same calculation and region breakdown for the natural enzyme
KSI complexed with the inhibitor 19NT (thereby only relevant for the reactant bound state).
Table 2 shows that the electric field environment for the natural enzyme is qualitatively different,
with the scaffold contributing ~25% of stabilization of the substrate bound complex, in contrast
with the destabilization observed for the reactant state for the designed enzymes. This result
generalizes to  the other bonds as well,  with the exception that  the C-N bond receives some
support from the scaffold in the evolved KE07 enzyme, whereas the more important N-O bond is
negatively impacted by the scaffold (Table S6 and S7). 
Table 2: Chemical Positioning vs. Electric Field Environment in designed and natural enzymes.
The magnitude of the electric field at  the C-H bond in either the EL and EL † states for the
designed KE07 and KE70 enzymes and the best LDE variants. The active site is defined by
residues  within  5  Å  from  the  substrate  (see  SI  for  residue  numbers),  while  the  protein
environment is summed over all residues outside this region. Solvent includes waters in the neck
of the TIM barrel as well as the surrounding hydration and bulk water. Positive sign indicates
field supporting bond breaking. For comparison with a natural enzyme, a similar breakdown for
the  C=O bond of  inhibitor  19NT in KSI has  been provided.  Fields are  reported in  units  of
MV/cm. 
Region KE07 
Design
KE07 R7
Variant
KE70 
 Design
KE70 R6 
Variant
KSI 
Natural
EL EL† EL EL† EL EL† EL EL† EL
Base 86.3 103.6 142.2 144.3 46.1 65.1 61.4 80.1 N/A
Active 1.0 11.2 2.0 8.3 16.7 23.1 2.3 2.9 41.1
Solvent -15.6 -19.2 -22.6 -20.2 2.9 0.7 1.9 2.8 0.5
Protein -24.1 -26.8 -40.1 -24.1 -12.2 -11.3 -11.6 -9.1 16.0
These observations on KE07 and KE70 go a long way to explain why de novo enzymes
are so poor to begin with, and why LDE is such a limited strategy for improving them. By using
an “arbitrary” protein scaffold as a container for the active site theozyme, and one that may also
orient  water  solvent  in  such a  way that  are  optimized for  the  scaffold and not  the  reactive
chemistry, it should not be surprising the electric field environments are highly non-optimized for
stabilizing the reactant or transition state. Hence the only tractable LDE strategy is to optimize
the electrostatic fields locally at the active site, as was done for KE07, or utilize other chemical
positioning strategies or ways to increase the basicity of the catalytic base through creation of a
more non-polar active site, as found for KE70. 
DISCUSSION 
At present computational approaches have yielded de novo enzyme designs that are minimally
competent, and therefore there is a necessary reliance on laboratory directed evolution to bridge
the  performance gap to  compete  at  the  level  of  catalytic  antibodies,  but  even then they are
nowhere  near  the  catalytic  efficiencies  of  natural  enzymes1.  An  important  aspect  that  helps
explain  the  incredible  performance  of  natural  enzymes  is  that  they  have  optimized  folded
structures that create favorable electric fields from the entire protein and perhaps the surrounding
solvent, not just the active site, to stabilize the transition state. In order to understand a natural
enzyme’s high catalytic proficiency, Warshel has suggested that an enzyme structural fold creates
a pre-organized electrostatic environment, not found in bulk aqueous solution, that preferentially
stabilizes the transition state charge distribution compared to the substrate reactant. 
We conjecture that LDE is ultimately a limited strategy for improving de novo enzymes
since it would require wholesale reengineering of most of the sequence of the scaffold; if such
sequences prove to be unstable for maintaining the fold, it would extend the need to the creation
of a new protein fold, that is beyond the capacity of any realistically sized LDE libraries, not to
mention human time and patience. Thus there are more limited options due to the vast reduction
in the optimizable sequence space that is now largely restricted to chemical positioning in the
active site. While it is true that nothing in principle limits LDE from exploring all mutations,
high throughput assays will still trap active site modifications more often than not, since scaffold
optimization would be a small cumulative effect from round to round. 
If we were to take KSI as a reference point for the free energy stabilization attributable to
local active site contributions29, we would expect at most a 3 order of magnitude improvement
using LDE.  To support  that  estimate,  at  present  all  known attempts  to  further  optimize  the
artificial  Kemp  Eliminases  biocatalysts  using  LDE  have  yielded  as  little  as  one  order  of
magnitude (the result for KE07 and KE70 after 6-7 LDE rounds beyond which no improvement
was realized),  to the best result obtained after 17 LDE rounds applied to the  in silico design
Kemp Eliminase HG310,  yielding a kcat for HG3.17 that is 700 s-1 relative to 0.68 s-1 for the
design17. We do not mean to diminish what is clearly a success story, but we hypothesize that it
may be unlikely for any designed enzyme to further improve once active site precision using
LDE has been optimized, and one must now venture further into the greater protein scaffold to
find the next orders of magnitude for improvement.
While de novo enzymatic reactions would most productively benefit from optimization of
the protein scaffold utilizing electric field optimization as guidance, it should happen in earlier
stages  of  the  computational  design.  For  KE07  the  cluster  of  interactions  involving Lys222,
Ser48, Ile7 (Asp7) and Asp224-water have allowed for better positioning of the Glu101 base to
act on the substrate, but with counterproductive electric field effects on the substrate that raises
the activation free energy. The primary problem in their removal is that these residues are “baked
in” to perform other benefits to support the catalytic purpose of KE07, but the evolved enzyme
has to develop even more optimized catalytic base electric fields to compensate. Both KE07 and
KE70 may have reached a cul de sac in regards further improvement in the active site after 6-7
rounds of LDE due to such electric field compensations.
CONCLUSIONS 
In this study we have used a robust model for electrostatics, the AMOEBA polarizable force
field40-42, to calculate electric fields for the designed KE07 and KE70 enzymes and for the best
variants  that  were  improved  under  laboratory  directed  evolution.  By  calculating  the  field
directions that are productively aligned with the breakage of the C-H and N-O single bonds and
the formation of a C≡N triple bond for the small ligand substrate 5-nitrobenzisoxazole, we can
assess the electrostatic free energy stabilization of the transition state  relative to the reactant
state. For KE07 it was found that the enhanced catalytic activity of the best R7 LDE variant
stemmed from mutations  that  improved  the  electric  fields  locally  in  the  active  site,  mostly
attributed to the catalytic base, for stabilizing the transition state, while in KE70 the electric field
enhancements to the transition state for its best LDE variant were more modest and completely
isolated to the catalytic His17-Asp45 dyad. In both enzymes we find that the oxy-anion hole was
not optimized by LDE, and in fact that deficiency has been a known target for improvement in
the  design  of  Kemp  Eliminases.  Finally,  regardless  of  the  Kemp  Eliminase  construct  (i.e.
designed or LDE optimized), we showed that the electrostatic environment of the protein and
solvent are counterproductive in their contribution to stabilizing the transition state.
We suggest that  LDE is ultimately a limited strategy for improving  de novo enzymes
since we have argued that it may be largely restricted to optimization of chemical positioning in
the active site, thus yielding up to a ~3 order magnitude improvement that we suggest is an upper
bound estimate based on the best known de novo Kemp Eliminase HG3.1717, as well as based on
estimates made on naturally occurring enzymes such as KSI29. It might be suggested that the
relatively  modest  LDE  throughput  of  the  assays  used  to  optimize  these  particular  Kemp
eliminases may not be the best benchmarks for what is actually attainable under LDE. But even
in the case of an ultra-high-throughput assay in which Obexer et al. were able to optimize an
aldolase  that  is  >5 orders  of  magnitude  better  than  the  original  computational  design45,  the
starting activity itself was extremely poor (kcat  ~ 0.00005 s-1) resulting in a final kcat that is ~ 10 s-
1, similar to that obtained for the designed KE07 enzyme. I.e. the upper bound estimate for LDE
improvement for  de novo enzymes is an absolute one instead of being relative to the starting
design. Our upper bound estimate on LDE improvement is drawn from the Kemp Eliminases14-15,
18, an aldolase45, and KSI29, and would require additional tests of other designed enzymes to see if
the “speed limit” is operative more generally. 
Therefore de  novo enzymatic  reactions  could  take  a  different  tack  by  focusing  on
optimization of the protein scaffold in early stages of the computational design, utilizing electric
field optimization as guidance. One simple optimization strategy would scan a range of known
protein scaffolds with the  theozyme present, and ranking them according to their electric field
contributions. Widening the repertoire of folds considered for the design of Kemp eliminases
beyond the TIM barrel is also likely to be beneficial. For example in the design process of the
Kemp  Eliminases,  TIM  barrels  show  up  disproportionately  (71%  of  low-energy  structures)
compared to their occurrence in natural enzymes (10%). Considering motifs of enzymes like KSI
that catalyze a proton transfer reaction involving a labile hydrogen from an aromatic motif with
high efficiency might be considered as an alternative scaffold. Even with the current TIM barrels
used in the Kemp Eliminases one can imagine a better enzyme scaffold optimization by focusing
on polar or charged residue mutations on the protein surface46 to  better  pre-organize solvent
dipoles, whose integrated electric field could be quite large; every ~30 MV/cm improvement in
electric field alignment of the solvent on the active site would result in an order of magnitude of
improvement in the catalytic rate. 
SUPPORTING INFORMATION.  Parameterization,  dipole  moment  and  active  site  residue
details.  Tables  for  sequence  of  KE07/KE70,  dipole  moments,  preorganization/reorganization
energy breakup, field values for specific residues, scaffold and solvent at the 3 bonds.
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